BioNTech SE (BNTX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $87.71, -2.76% vs the prior close of $90.20.
- Volume 1.10M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BNTX dips 2.8% to $87.71, a 3-month low. Closed at $87.71, -2.76% vs the prior close of $90.20. Day range $87.36–$90.14, opened at $90.14.
BNTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BNTX dips 2.8% to $87.71, a 3-month low
- Closed at $87.71, -2.76% vs the prior close of $90.20. Day range $87.36–$90.14, opened at $90.14.
- Volume was 1.10M shares, 0.9x its 50-day average of 1.28M.
- Price is -11.2% vs its 50-day average ($98.78) and -10.2% vs its 200-day average ($97.68).
- 52-week range $79.52–$124.00; today's close sits at 18% of that range, 29.3% below the 52-week high.
Oct 15, 2026 — BNTX rises 1.7% to $90.20
- Closed at $90.20, +1.74% vs the prior close of $88.66. Day range $88.45–$90.72, opened at $88.92.
- Volume was 1.08M shares, 0.8x its 50-day average of 1.29M.
- Price is -8.7% vs its 50-day average ($98.85) and -7.7% vs its 200-day average ($97.71).
- 52-week range $79.52–$124.00; today's close sits at 24% of that range, 27.3% below the 52-week high.
Oct 14, 2026 — BNTX dips 0.4% to $88.66, a 3-month low, 3 down days in a row
- Closed at $88.66, -0.39% vs the prior close of $89.01. Day range $88.57–$90.50, opened at $89.01.
- Volume was 1.13M shares, 0.9x its 50-day average of 1.31M.
- Price is -10.3% vs its 50-day average ($98.89) and -9.3% vs its 200-day average ($97.74).
- 52-week range $79.52–$124.00; today's close sits at 21% of that range, 28.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — BNTX slides 7.1% to $89.01, a 3-month low
- Closed at $89.01, -7.13% vs the prior close of $95.84. Day range $88.85–$93.08, opened at $92.36.
- Volume was 1.95M shares, 1.5x its 50-day average of 1.29M.
- Price is -10.0% vs its 50-day average ($98.94) and -9.0% vs its 200-day average ($97.77).
- 52-week range $79.52–$124.00; today's close sits at 21% of that range, 28.2% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — BNTX dips 1.2% to $95.84
- Closed at $95.84, -1.16% vs the prior close of $96.96. Day range $95.75–$98.60, opened at $97.61.
- Volume was 1.28M shares, 1.0x its 50-day average of 1.28M.
- Price is -3.2% vs its 50-day average ($99.01) and -2.0% vs its 200-day average ($97.80).
- 52-week range $79.52–$124.00; today's close sits at 37% of that range, 22.7% below the 52-week high.
Oct 9, 2026 — BNTX jumps 5.3% to $96.96
- Closed at $96.96, +5.32% vs the prior close of $92.06. Day range $92.30–$97.40, opened at $92.45.
- Volume was 1.32M shares, 1.0x its 50-day average of 1.28M.
- Price is -2.0% vs its 50-day average ($98.90) and -0.8% vs its 200-day average ($97.79).
- 52-week range $79.52–$124.00; today's close sits at 39% of that range, 21.8% below the 52-week high.
Oct 8, 2026 — BNTX slides 3.3% to $92.06, a 1-month low, 3 down days in a row
- Closed at $92.06, -3.35% vs the prior close of $95.25. Day range $91.64–$94.45, opened at $93.81.
- Volume was 1.21M shares, 0.9x its 50-day average of 1.27M.
- Price is -6.8% vs its 50-day average ($98.82) and -5.8% vs its 200-day average ($97.76).
- 52-week range $79.52–$124.00; today's close sits at 28% of that range, 25.8% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — BNTX dips 0.5% to $95.25, a 1-month low
- Closed at $95.25, -0.50% vs the prior close of $95.73. Day range $93.92–$97.46, opened at $95.17.
- Volume was 828.00K shares, 0.7x its 50-day average of 1.27M.
- Price is -3.6% vs its 50-day average ($98.84) and -2.6% vs its 200-day average ($97.77).
- 52-week range $79.52–$124.00; today's close sits at 35% of that range, 23.2% below the 52-week high.
Oct 6, 2026 — BNTX dips 2.0% to $95.73, a 1-month low
- Closed at $95.73, -1.96% vs the prior close of $97.64. Day range $95.31–$100.02, opened at $99.49.
- Volume was 899.40K shares, 0.7x its 50-day average of 1.27M.
- Price is -3.1% vs its 50-day average ($98.78) and -2.1% vs its 200-day average ($97.75).
- 52-week range $79.52–$124.00; today's close sits at 36% of that range, 22.8% below the 52-week high.
Oct 5, 2026 — BNTX rises 0.8% to $97.64
- Closed at $97.64, +0.76% vs the prior close of $96.90. Day range $95.20–$98.79, opened at $96.74.
- Volume was 1.44M shares, 1.1x its 50-day average of 1.26M.
- Price is -1.1% vs its 50-day average ($98.69) and -0.1% vs its 200-day average ($97.73).
- 52-week range $79.52–$124.00; today's close sits at 41% of that range, 21.3% below the 52-week high.
Oct 2, 2026 — BNTX ends flat (+0.1%) to $96.90
- Closed at $96.90, +0.05% vs the prior close of $96.85. Day range $96.22–$98.00, opened at $97.35.
- Volume was 696.00K shares, 0.6x its 50-day average of 1.25M — lighter than usual.
- Price is -1.6% vs its 50-day average ($98.52) and -0.8% vs its 200-day average ($97.70).
- 52-week range $79.52–$124.00; today's close sits at 39% of that range, 21.9% below the 52-week high.
BNTX latest news & SEC filings
Every SEC filing by or about BNTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sahin Ugur sold 27,000 shares at $92.31 (≈$2.49M) on Oct 8, 2026; now holds 36,209
- Sahin Ugur sold 36,209 shares at $95.37 (≈$3.45M) on Oct 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sahin Ugur sold 24,000 shares at $95.86 (≈$2.30M) on Oct 7, 2026; now holds 63,209
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sahin Ugur sold 72,000 shares at $97.23 (≈$7.00M) on Oct 5, 2026; now holds 108,209
- Sahin Ugur sold 21,000 shares at $96.81 (≈$2.03M) on Oct 6, 2026; now holds 87,209
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sahin Ugur sold 17,000 shares at $97.46 (≈$1.66M) on Oct 1, 2026; now holds 197,209
- Sahin Ugur sold 17,000 shares at $96.72 (≈$1.64M) on Oct 2, 2026; now holds 180,209
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sahin Ugur sold 34,000 shares at $98.26 (≈$3.34M) on Sep 29, 2026; now holds 246,209
- Sahin Ugur sold 32,000 shares at $98.12 (≈$3.14M) on Sep 30, 2026; now holds 214,209
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sahin Ugur sold 27,000 shares at $98.69 (≈$2.66M) on Sep 25, 2026; now holds 314,209
- Sahin Ugur sold 34,000 shares at $98.47 (≈$3.35M) on Sep 28, 2026; now holds 280,209
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 3, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade BNTX
- How much it moves: over the last 20 sessions the average daily move was 1.84% (largest 7.1%).
- Liquidity: about 1.02M shares (≈$89.61M) trade per day on average.
- 52-week position: $87.71 vs a range of $79.52–$124.00 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Ugur Sahin sold 32,000 shares on Sep 30, 2026.
- Latest filings: 6-K Oct 13, 2026; 6-K Sep 18, 2026; 6-K Sep 14, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
BNTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 90.14 | 90.14 | 87.36 | 87.71 | 1.10M |
| Oct 15, 2026 | 88.92 | 90.72 | 88.45 | 90.20 | 1.08M |
| Oct 14, 2026 | 89.01 | 90.50 | 88.57 | 88.66 | 1.13M |
| Oct 13, 2026 | 92.36 | 93.08 | 88.85 | 89.01 | 1.95M |
| Oct 12, 2026 | 97.61 | 98.60 | 95.75 | 95.84 | 1.28M |
| Oct 9, 2026 | 92.45 | 97.40 | 92.30 | 96.96 | 1.32M |
| Oct 8, 2026 | 93.81 | 94.45 | 91.64 | 92.06 | 1.21M |
| Oct 7, 2026 | 95.17 | 97.46 | 93.92 | 95.25 | 828.00K |
| Oct 6, 2026 | 99.49 | 100.02 | 95.31 | 95.73 | 899.40K |
| Oct 5, 2026 | 96.74 | 98.79 | 95.20 | 97.64 | 1.44M |
| Oct 2, 2026 | 97.35 | 98.00 | 96.22 | 96.90 | 696.00K |
| Oct 1, 2026 | 97.59 | 99.49 | 96.60 | 96.85 | 820.00K |
| Sep 30, 2026 | 98.28 | 99.14 | 96.90 | 98.30 | 845.10K |
| Sep 29, 2026 | 98.43 | 99.79 | 97.60 | 98.57 | 736.90K |
| Sep 28, 2026 | 97.00 | 100.21 | 96.64 | 99.08 | 781.20K |
| Sep 25, 2026 | 99.51 | 100.01 | 97.73 | 98.52 | 580.00K |
| Sep 24, 2026 | 97.62 | 99.93 | 97.05 | 99.26 | 803.40K |
| Sep 23, 2026 | 100.61 | 101.31 | 98.31 | 98.46 | 1.09M |
| Sep 22, 2026 | 98.00 | 102.23 | 97.46 | 100.87 | 1.05M |
| Sep 21, 2026 | 97.25 | 98.98 | 96.61 | 98.00 | 800.80K |
About BioNTech SE
BioNTech SE (BNTX) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in MAINZ, Germany. State of incorporation: Germany. Fiscal year ends December 31. SEC CIK 1776985.
BNTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Nicola Claire Blackwood | Director | Mar 25, 2026 |
| Helmut Wolfgang Jeggle | Director | Mar 18, 2026 |
| Iris Katharina Low-Friedrich | Director | Jun 26, 2026 |
| Anja Morawietz | Director | Mar 25, 2026 |
| Michael Motschmann | Director | Mar 18, 2026 |
| Susanne Schaffert | Director | Jun 26, 2026 |
| Rudolf Staudigl | Director | Mar 25, 2026 |
| Ulrich Wandschneider | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Annemarie Hanekamp | Chief Commercial Officer | May 13, 2026 |
| Kylie Jimenez | Chief People Officer | May 13, 2026 |
| Sierk Poetting | Chief Operating Officer | May 13, 2026 |
| James Timothy Patrick Ryan | See remarks. | May 13, 2026 |
| Ugur Sahin | Chief Executive Officer | Sep 30, 2026 |
| Ozlem Tureci | Chief Medical Officer | Mar 18, 2026 |
| Gomez Ramon Zapata | Chief Financial Officer | May 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 30, 2026 | Ugur Sahin | Sale | 32,000 | $98.12 |
| Sep 30, 2026 | Ugur Sahin | Sale | 32,000 | $98.12 |
| Sep 30, 2026 | Ugur Sahin | Sale | 32,000 | $98.12 |
| Sep 30, 2026 | Ugur Sahin | Sale | 32,000 | $98.12 |
| Sep 29, 2026 | Ugur Sahin | Sale | 34,000 | $98.26 |
| Sep 29, 2026 | Ugur Sahin | Sale | 34,000 | $98.26 |
| Sep 29, 2026 | Ugur Sahin | Sale | 34,000 | $98.26 |
| Sep 29, 2026 | Ugur Sahin | Sale | 34,000 | $98.26 |
| Sep 28, 2026 | Ugur Sahin | Sale | 34,000 | $98.47 |
| Sep 28, 2026 | Ugur Sahin | Sale | 34,000 | $98.47 |
| Sep 28, 2026 | Ugur Sahin | Sale | 34,000 | $98.47 |
| Sep 28, 2026 | Ugur Sahin | Sale | 34,000 | $98.47 |
| Sep 25, 2026 | Ugur Sahin | Sale | 27,000 | $98.69 |
| Sep 25, 2026 | Ugur Sahin | Sale | 27,000 | $98.69 |
| Sep 25, 2026 | Ugur Sahin | Sale | 27,000 | $98.69 |
BNTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BNTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BNTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.